$2 Trillion Disappears Because of Fed's Secretive New Move

$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being carried out by the Fed that has nothing to do with lowering or raising interest rates... but could soon have an enormous impact on your wealth.

Michael Klayko Biography and Net Worth

Director of Veradigm

Michael A. Klayko has served as chairman of the board since March 2014. He currently serves as the chief executive officer of MKA Capital, an investment company focused on technology investments. Previously, he was chief executive officer of AOptix Technologies, Inc., a privately held provider of wireless communications and mobile network solutions, and chief executive officer of Brocade Communications Systems, Inc., a comprehensive network solutions provider. He has held executive positions, including CEO, at Rhapsody Networks, Inc., McDATA Corp., EMC Corporation, Hewlett-Packard Company and IBM Corporation. Within the past five years, Michael has served as a director of Bally Technologies, Inc., a publicly traded manufacturer of slot machines and other gaming technologies; PMC-Sierra, Inc., a publicly traded semiconductor company; and several other private companies in the technology industry. Among other qualifications, he brings more than 35 years of leadership experience in the technology industry, as well as extensive experience in the management of worldwide operations, sales and support.

What is Michael Klayko's net worth?: The estimated net worth of Michael Klayko is at least $366,519.50 as of June 8th, 2021. Mr. Klayko owns 38,581 shares of Veradigm stock worth more than $366,520 as of December 22nd. This net worth evaluation does not reflect any other assets that Mr. Klayko may own. Learn More about Michael Klayko's net worth.
How do I contact Michael Klayko?: The corporate mailing address for Mr. Klayko and other Veradigm executives is 222 MERCHANDISE MART PLAZA SUITE 2024, CHICAGO IL, 60654. Veradigm can also be reached via phone at (800) 334-8534 and via email at [email protected]. Learn More on Michael Klayko's contact information.
Has Michael Klayko been buying or selling shares of Veradigm?: Michael Klayko has not been actively trading shares of Veradigm during the last ninety days. Most recently, Michael Klayko sold 28,000 shares of the business's stock in a transaction on Tuesday, June 8th. The shares were sold at an average price of $18.03, for a transaction totalling $504,840.00. Following the completion of the sale, the director now directly owns 38,581 shares of the company's stock, valued at $695,615.43. Learn More on Michael Klayko's trading history.
Who are Veradigm's active insiders?: Veradigm's insider roster includes Elizabeth Altman (Director), Paul Black (CEO), Greg Garrison (Director), Lisa Khorey (Insider), Michael Klayko (Director), and Richard Poulton (CFO). Learn More on Veradigm's active insiders.

Michael Klayko Insider Trading History at Veradigm

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
6/8/2021	Sell	28,000	$18.03	$504,840.00	38,581
6/4/2021	Sell	113,000	$18.00	$2,034,000.00	66,581
6/13/2018	Buy	4,000	$12.52	$50,080.00	117,315
8/18/2014	Buy	3,500	$14.41	$50,435.00
8/15/2013	Buy	10,000	$14.80	$148,000.00	24,225

Michael Klayko Buying and Selling Activity at Veradigm

Veradigm Company Overview

Veradigm Inc., a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions. The company operates through two segments, Hospitals and Large Physician Practices, and Veradigm. The Hospitals and Large Physician Practices segment provides integrated clinical and financial management solutions, which primarily include EHR-related software; and related installation, support and maintenance, outsourcing, private cloud hosting, and revenue cycle management services. The Veradigm segment offers payer and life sciences solutions, which are primarily targeted at payers, life sciences companies, and other healthcare stakeholders; and software applications for patient engagement and EHR software to single-specialty, and small and mid-sized physician practices, including related clinical, financial, administrative, and operational solutions. Its solutions enable clients to transition, analyze, and coordinate care, and enhance the healthcare delivery across the care community. The company serves physicians, hospitals, governments and militaries, health systems, health plans, life-sciences companies, retail clinics, surgery centers, retail pharmacies, pharmacy benefit managers, insurance companies, employer wellness clinics, consumers, lab companies, urgent care facilities, and venture capital firms, as well as post-acute organizations, such as home health and hospice agencies. The company was formerly known as Allscripts Healthcare Solutions, Inc. and changed its name to Veradigm Inc. in January 2023. Veradigm Inc. was founded in 1986 and is headquartered in Chicago, Illinois.

Today's Range

Now: $9.50

$9.50

$9.52

50 Day Range

MA: $9.98

$9.00

$11.30

2 Week Range

Now: $9.50

$5.01

$11.80

Volume

160,761 shs

Average Volume

1,475,412 shs

Market Capitalization

$1.02 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.63